Sector Update: Health Care Stocks Advance Premarket Friday
Amneal Resubmits New Drug Application for Migraine Treatment, Diabetes Drug Is Approved
Express News | Amneal Pharmaceuticals Inc - FDA Review of Dhe Autoinjector Nda Expected by Q2 2025
Express News | Amneal Resubmits Dhe Autoinjector New Drug Application and Receives U.S. FDA Approval of Exenatide, Its First Generic Injectable GLP-1 Agonist
Amneal Resubmits DHE Autoinjector New Drug Application and Receives U.S. FDA Approval of Exenatide, Its First Generic Injectable GLP-1 Agonist
Truist Financial Maintains Amneal Pharmaceuticals(AMRX.US) With Buy Rating